0000000000264134

AUTHOR

Inmaculada Berenguer

showing 5 related works from this author

Tetrahydroisoquinolines as dopaminergic ligands: 1-Butyl-7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity …

2009

International audience; Three series of 1-substituted-7-chloro-6-hydroxy-tetrahydroisoquinolines (1-butyl-, 1-phenyl- and 1-benzyl derivatives) were prepared to explore the influence of each of these groups at the 1-position on the affinity for dopamine receptors. All the compounds displayed affinity for D(1)-like and/or D(2)-like dopamine receptors in striatal membranes, and were unable to inhibit [(3)H]-dopamine uptake in striatal synaptosomes. Different structure requirements have been observed for adequate D(1) or D(2) affinities. This paper details the synthesis, structural elucidation, dopaminergic binding assays, structure-activity relationships (SAR) of these three series of isoquin…

MaleModels MolecularStereochemistryDopamineClinical BiochemistryPharmaceutical ScienceMotor Activity010402 general chemistryLigands01 natural sciencesBiochemistryReceptors Dopaminechemistry.chemical_compoundMiceStructure-Activity RelationshipDopamineTetrahydroisoquinolinesDrug DiscoverymedicineStructure–activity relationshipAnimalsReceptorMolecular Biology010405 organic chemistryTetrahydroisoquinolineReceptors Dopamine D2Receptors Dopamine D1[SCCO.NEUR]Cognitive science/NeuroscienceOrganic ChemistryDopaminergicAntagonistAntidepressive AgentsCorpus Striatum3. Good health0104 chemical sciencesRatschemistryDopamine receptorHydroxyquinolinesMolecular MedicineLead compoundmedicine.drugProtein Binding
researchProduct

Structure-activity relationship of dopaminergic halogenated 1-benzyl-tetrahydroisoquinoline derivatives

2009

Two series of halogenated 1-benzyl-7-chloro-6-hydroxy-tetrahydroisoquinolines were prepared to explore the influence of each series on the affinity for dopamine receptors. All the compounds displayed a high affinity for D(1)-like and/or D(2)-like dopamine receptors in striatal membranes, although they were unable to inhibit [(3)H]-dopamine uptake in striatal synaptosomes. The halogen placed on the benzylic ring in 1-benzyl-THIQs, compounds of the series 1, 2'-bromobenzyl derivatives with K(i) values into the nanomolar range, and the series 2, 2',4'-dichlorobenzyl-THIQ homologues, proves to be an important factor to modulate affinity at dopamine receptor. (C) 2009 Elsevier Masson SAS. All ri…

inorganic chemicalsHalogenationStereochemistryChemical synthesisReceptors DopamineStructure-Activity Relationshipchemistry.chemical_compoundStructure–activity relationshipsDopamineTetrahydroisoquinolinesBiogenic amineDrug DiscoverymedicineAnimalsStructure–activity relationshipRats WistarNeurotransmitterDopamine receptorsSTRUCTURE-ACTIVITY RELATIONSHIPSPharmacologychemistry.chemical_classification1-Halogenated benzyl-7-chloro-6-hydroxy-tetrahydroisoquinolinesDopamine uptakReceptors Dopamine D2Receptors Dopamine D1Otras Ciencias QuímicasOrganic ChemistryDopaminergicCiencias QuímicasGeneral MedicineBinding1-Halogenated benzyl-7-chloro-6-hydroxytetrahydroisoquinolinesRatschemistryDopamine receptorDOPAMINE UPTAKECatecholamineFemaleCIENCIAS NATURALES Y EXACTASProtein Bindingmedicine.drug
researchProduct

Novel oxybispyridylboronic acids: synthesis and study of their reactivity in Suzuki-type cross-coupling reactions

2007

Abstract This paper sets forth the synthesis of novel oxybispyridylboronic acids, which are prepared from the corresponding halo-oxybispyridines via halogen–metal exchange using n-butyllithium and treatment with triisopropylborate. A range of efficient cross-coupling reactions of these novel boronic acids with selected aryl halides is described. This strategy produces novel pyridylethers of interest in cholinergic medicinal chemistry.

inorganic chemicalschemistry.chemical_compoundchemistryArylOrganic ChemistryDrug DiscoveryOrganic chemistryHalideReactivity (chemistry)General MedicineBiochemistryCombinatorial chemistryCoupling reactionTetrahedron
researchProduct

Efficient synthesis and structural analysis of new dioxopiperazine isoquinolines

2006

Abstract We report herein the synthesis of new dioxopiperazine isoquinolines using the Pictet–Spengler cyclisation. Our synthetic strategy for the preparation of two new compounds ( 5 , 6 ), with a tetrahydro-6H-pyrazino[1,2-b]isoquinoline-1,4-dione moiety was developed in only four steps. To understand better the crucial step of the synthesis reported here, theoretical calculations using semiempirical (PM3), ab initio and DFT computations were carried out on a reduced system model. The structure of chlorohydrate water solvate of tetrahydro (2-piperidinylethyl)-6H-pyrazino [1,2-b]isoquinoline-1,4-dione ( 6·HCl·2H2O ) was determined by X-ray diffraction. Theoretical calculations (RHF/3-21G a…

DiffractionChemistryComputational chemistryOrganic ChemistryDrug DiscoverymedicineAb initioMoietyBiochemistryChloridemedicine.drugIonTetrahedron
researchProduct

Synthesis of new melatoninergic hexahydroindenopyridines

2014

Hexahydroindenopyridine (HHIP) is an interesting heterocyclic framework that contains an indene core similar to ramelteon. This type of tricyclic piperidines aroused our interest as potential melatoninergic ligands. Melatonin receptor ligands have applications in insomnia and depression. We report herein an efficient two-step method to prepare new HHIP by the reaction of an enamine with 3-bromopropylamine hydrobromide. Some synthesized compounds showed moderate affinity for melatonin receptors in the nanomolar or low micromolar range. Furthermore, the methylenedioxy HHIPs 2d (N-phenylacetamide) and 2f (N,N-diethylacetamide), exhibited high selectivity at MT1 or MT2 receptors, respectively, …

StereochemistryClinical BiochemistryRamelteonPharmaceutical ScienceLigandsHeterocyclic Compounds 4 or More RingsBiochemistryMelatonin receptorMethylenedioxyEnamineMelatoninStructure-Activity Relationshipchemistry.chemical_compoundDrug DiscoverymedicineHumansIndeneMolecular Biologychemistry.chemical_classificationDose-Response Relationship DrugMolecular StructureReceptor Melatonin MT2HydrobromideReceptor Melatonin MT1Organic ChemistryHEK293 CellschemistryMolecular MedicineTricyclicmedicine.drugBioorganic & Medicinal Chemistry Letters
researchProduct